News

February 17, 2026
PRNewswire
Artificial Intelligence, News

Beactica and KU Leuven Win €2.5M EIC Grant to Advance BEA-17 for Glioblastoma

The Beactica EIC grant marks a major step forward in the development of a novel precision therapy for glioblastoma. Beactica Therapeutics AB, in collaboration with leading researchers at KU...

February 17, 2026
PRNewswire
Artificial Intelligence, News

Unitree Robots Deliver Cyber Real Kung Fu at 2026 Spring Festival Gala

The Unitree Spring Festival Gala robots stunned global audiences at the 2026 Spring Festival Gala hosted by China Media Group. As the official robot partner for the third time,...

February 17, 2026
Business Wire
Biotechnology, News

Sensorion Announces CEO Transition and Interim Leadership Appointment

The Sensorion CEO transition marks a significant leadership update for Sensorion (FR0012596468 – ALSEN), a clinical-stage biotechnology company developing innovative therapies for hearing loss disorders. The company confirmed that...

February 16, 2026
Business Wire
Artificial Intelligence, News

HPE Self-Driving Network Transforms Riyadh Air Metropolitano Stadium

The HPE self-driving network is powering a major digital transformation at the Riyadh Air Metropolitano Stadium, home of Atlético de Madrid. Through advanced AI-driven networking solutions, Hewlett Packard Enterprise...

February 16, 2026
Business Wire
Artificial Intelligence, News

Global Survey Shows Rising Investment in AI Decision Intelligence

AI Decision Intelligence survey findings reveal that executives are prioritizing advanced analytics to improve credit risk and fraud decisions. According to new research sponsored by Provenir, 60% of global...

February 16, 2026
Business Wire
Biotechnology, News

Worldwide Clinical Trials Completes Catalyst Acquisition

Worldwide Clinical Trials acquisition marks a significant expansion in the global contract research organization (CRO) landscape. Worldwide Clinical Trials has officially completed its acquisition of Catalyst Clinical Research, a...

February 16, 2026
Business Wire
Artificial Intelligence, News

Chronus Launches Change Adoption Solution to Drive Behavior Change

The Chronus Change Adoption solution is designed to help organizations address the human side of transformation. Chronus, a mentoring and connection platform for the future of work, has introduced...

February 16, 2026
PRNewswire
Cloud, Internet of Things (IoT), News

Pedestrian Entrance Control Systems Market to Reach US$3.4 Billion by 2033

The pedestrian entrance control systems market is set for strong growth, with projections indicating it will reach US$3.4 billion by 2033. According to insights from Persistence Market Research, the...

February 16, 2026
PRNewswire
Healthcare, News

Retevmo Adjuvant Therapy Improves Event-Free Survival in RET+ NSCLC

Retevmo adjuvant therapy has demonstrated a substantial event-free survival benefit in early-stage RET fusion-positive non-small cell lung cancer (NSCLC). Eli Lilly and Company announced positive topline results from the...

February 16, 2026
Business Wire
Biotechnology, News

Nucleome Therapeutics Appoints Dr. Michelle Morrow as Chief Scientific Officer

Nucleome Therapeutics CSO appointment marks a significant leadership milestone as Nucleome Therapeutics names Dr. Michelle Morrow as its new Chief Scientific Officer, effective 23 February 2026. The appointment strengthens...